VivoSim Labs (VIVS) Cash from Operations (2010 - 2026)
VivoSim Labs (VIVS) posted quarterly Cash from Operations of 2227000.0 for Q1 2026, down 9.43% year-over-year from 2459004.34 in Q1 2025, and up 3.17% quarter-over-quarter from 2300000.0 in Q4 2025.
VivoSim Labs (VIVS) Cash from Operations (2010 - 2026) Analysis & Trends
VivoSim Labs' Cash from Operations history runs 17 years deep, the most recent figure standing at 2227000.0 for Q1 2026.
- In Q1 2026, Cash from Operations fell 9.43% year-over-year to 2227000.0; the TTM figure through Mar 2026 stood at 10827000.0 (down 14.44% YoY), while the FY2026 annual figure was 10827000.0, down 14.44% from the prior year.
- Cash from Operations for Q1 2026 stood at 2227000.0, up from 2300000.0 in the prior quarter.
- The five-year high for Cash from Operations was 1541000.0 in Q1 2022, with the low at 5311000.0 in Q2 2023.
- The 5-year median for Cash from Operations is 2642000.0 (2024), against an average of 2875882.35.
- The sharpest annual moves came in 2023 and 2024: Cash from Operations tumbled 207.14% in 2023, then surged 48.86% in 2024.
- VivoSim Labs' Cash from Operations stood at 3044000.0 in 2022, then fell by 15.7% to 3522000.0 in 2023, then soared by 48.86% to 1801000.0 in 2024, then dropped by 27.71% to 2300000.0 in 2025, then climbed by 3.17% to 2227000.0 in 2026.
- Business Quant data shows VIVS's Cash from Operations at 2227000.0 in Q1 2026, 2300000.0 in Q4 2025, and 2400000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.13 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 813.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -526.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 462.82 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 326.72 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 360.27 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -88.83 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 728.46 Mn |
| 10 | VivoSim Labs | 1.49 Mn | 1.49 Mn | - | -3.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -3.21 Mn |
| Jun 30, 2026 | -3.21 Mn |
| Mar 31, 2026 | -2.23 Mn |
| Mar 31, 2026 | -2.23 Mn |
| Dec 31, 2025 | -2.30 Mn |
| Dec 31, 2025 | -2.30 Mn |
| Sep 30, 2025 | -2.40 Mn |
| Sep 30, 2025 | -2.40 Mn |
| Jun 30, 2025 | -3.90 Mn |
| Jun 30, 2025 | -3.90 Mn |
| Mar 31, 2025 | -2.04 Mn |
| Mar 31, 2025 | -2.04 Mn |
| Dec 31, 2024 | -1.80 Mn |
| Dec 31, 2024 | -1.80 Mn |
| Sep 30, 2024 | -2.64 Mn |
| Sep 30, 2024 | -2.64 Mn |
| Jun 30, 2024 | -2.98 Mn |
| Jun 30, 2024 | -2.98 Mn |
| Mar 31, 2024 | -2.67 Mn |
| Mar 31, 2024 | -2.67 Mn |